These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23499640)

  • 1. Combined standard and novel immunosuppressive substances affect B-lymphocyte function.
    Matz M; Lehnert M; Lorkowski C; Fabritius K; Weber UA; Mashreghi MF; Neumayer HH; Budde K
    Int Immunopharmacol; 2013 Apr; 15(4):718-25. PubMed ID: 23499640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation.
    Matz M; Lehnert M; Lorkowski C; Fabritius K; Unterwalder N; Doueiri S; Weber UA; Mashreghi MF; Neumayer HH; Budde K
    Transpl Int; 2012 Oct; 25(10):1106-16. PubMed ID: 22816666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of everolimus and intravenous immunoglobulin on cell proliferation and apoptosis induction in the mixed lymphocyte reaction.
    Amet N; Gacad M; Petrosyan A; Pao A; Jordan SC; Toyoda M
    Transpl Immunol; 2010 Aug; 23(4):170-3. PubMed ID: 20609387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolic acid and intravenous immunoglobulin exert an additive effect on cell proliferation and apoptosis in the mixed lymphocyte reaction.
    Sharma KG; Radha R; Pao A; Amet N; Baden L; Jordan SC; Toyoda M
    Transpl Immunol; 2010 Jul; 23(3):117-20. PubMed ID: 20450974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin.
    Heidt S; Roelen DL; Eijsink C; van Kooten C; Claas FH; Mulder A
    Transplantation; 2008 Nov; 86(9):1292-300. PubMed ID: 19005412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of JAK3 and PKC via Immunosuppressive Drugs Tofacitinib and Sotrastaurin Inhibits Proliferation of Human B Lymphocytes In Vitro.
    Martina MN; Ramirez Bajo MJ; Bañon-Maneus E; Moya Rull D; Hierro-Garcia N; Revuelta I; Campistol JM; Rovira J; Diekmann F
    Transplant Proc; 2016 Nov; 48(9):3046-3052. PubMed ID: 27932144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal-sparing regimens employing new agents.
    Ruiz R; Klintmalm GB
    Curr Opin Organ Transplant; 2012 Dec; 17(6):619-25. PubMed ID: 23111644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin.
    Hoogduijn MJ; Crop MJ; Korevaar SS; Peeters AM; Eijken M; Maat LP; Balk AH; Weimar W; Baan CC
    Transplantation; 2008 Nov; 86(9):1283-91. PubMed ID: 19005411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses.
    Struijk GH; Minnee RC; Koch SD; Zwinderman AH; van Donselaar-van der Pant KA; Idu MM; ten Berge IJ; Bemelman FJ
    Kidney Int; 2010 Nov; 78(9):934-40. PubMed ID: 20703211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of drug action on B-cell proliferation and differentiation for mycophenolic acid, everolimus, and prednisolone.
    Haneda M; Owaki M; Kuzuya T; Iwasaki K; Miwa Y; Kobayashi T
    Transplantation; 2014 Feb; 97(4):405-12. PubMed ID: 24445924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the novel protein kinase C inhibitor AEB071 (Sotrastaurin) on rat cardiac allograft survival using single agent treatment or combination therapy with cyclosporine, everolimus or FTY720.
    Weckbecker G; Pally C; Beerli C; Burkhart C; Wieczorek G; Metzler B; Morris RE; Wagner J; Bruns C
    Transpl Int; 2010 May; 23(5):543-52. PubMed ID: 20003043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.
    Heidt S; Roelen DL; Eijsink C; Eikmans M; van Kooten C; Claas FH; Mulder A
    Clin Exp Immunol; 2010 Feb; 159(2):199-207. PubMed ID: 19922499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses.
    Berry V; Magill A; Yost M; Janosky J; Sindhi R
    Cytometry A; 2006 Feb; 69(2):95-103. PubMed ID: 16369935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of immunosuppressive drugs on neural stem/progenitor cell fate in vitro.
    Skardelly M; Glien A; Groba C; Schlichting N; Kamprad M; Meixensberger J; Milosevic J
    Exp Cell Res; 2013 Dec; 319(20):3170-81. PubMed ID: 24001738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic effects of everolimus on anti-CD3 antibody-stimulated T-lymphocyte proliferation and interleukin-10 synthesis in stable kidney-transplant patients.
    Böhler T; Waiser J; Lichter S; Schumann B; Neumayer HH; Kamar N; Budde K
    Cytokine; 2008 Jun; 42(3):306-11. PubMed ID: 18440821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of sotrastaurin clinical pharmacokinetics.
    Kovarik JM; Slade A
    Ther Drug Monit; 2010 Oct; 32(5):540-3. PubMed ID: 20683390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus synergizes with gefitinib in non-small-cell lung cancer cell lines resistant to epidermal growth factor receptor tyrosine kinase inhibitors.
    Dong S; Zhang XC; Cheng H; Zhu JQ; Chen ZH; Zhang YF; Xie Z; Wu YL
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):707-16. PubMed ID: 22941374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation.
    Matz M; Naik M; Mashreghi MF; Glander P; Neumayer HH; Budde K
    Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):103-13. PubMed ID: 21142580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens.
    Millán O; Jiménez O; Fortuna V; Barceló JJ; Brunet M
    Int J Immunopathol Pharmacol; 2006; 19(2):317-30. PubMed ID: 16831299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sotrastaurin and tacrolimus coadministration: effects on pharmacokinetics and biomarker responses.
    Kovarik JM; Stitah S; Slade A; Vitaliti A; Straube F; Grenet O; Winter S; Sfikas N; Seiberling M
    J Clin Pharmacol; 2010 Nov; 50(11):1260-6. PubMed ID: 20386017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.